Scientific Reports (Feb 2022)

External quality assessment of HIV-1 DNA quantification assays used in the clinical setting in Italy

  • Ilaria Vicenti,
  • Filippo Dragoni,
  • Alessia Giannini,
  • Anna Casabianca,
  • Francesca Lombardi,
  • Laura Di Sante,
  • Ombretta Turriziani,
  • Sara Racca,
  • Stefania Paolucci,
  • Alessia Lai,
  • Isabella Bon,
  • Isabella Abbate,
  • Gabriella Rozera,
  • Simone Belmonti,
  • Rossana Scutari,
  • Claudia Alteri,
  • Francesco Saladini,
  • Maurizio Zazzi,
  • Italian HIV DNA Network

DOI
https://doi.org/10.1038/s41598-022-07196-2
Journal volume & issue
Vol. 12, no. 1
pp. 1 – 11

Abstract

Read online

Abstract Total cell-associated HIV-1 DNA is a surrogate marker of the HIV-1 reservoir, however, certified systems for its quantification are not available. The Italian HIV DNA Network was launched to validate HIV-1 DNA quantification methods in use at University and Hospital labs. A quality control panel including HIV-1 DNA standards, reconstructed blood samples (RBSs) and DNA from different HIV-1 subtypes was blindly tested by 12 participating labs by quantitative real-time PCR (n = 6), droplet digital PCR (n = 3) or both (n = 3). The median 95% hit rate was 4.6 (3.7–5.5) copies per test and linearity in the tested range was excellent (R2 = 1.000 [1.000–1.000]). The median values obtained across labs were 3,370 (2,287–4,245), 445 (299–498), 59 (40–81) and 7 (6–11) HIV-1 DNA copies, for the 3,584, 448, 56 and 7-copy standards, respectively. With RBSs, measured values were within twofold with respect to the median in two thirds of cases. HIV-1 subtypes were missed (CRF01_AE by 3 labs) or underestimated by > 1 log (subtypes A, C, D, F by one lab; CRF01_AE by one lab; CRF02_AG by one lab). The overall performance was excellent with HIV-1 DNA standards, however detection of different HIV-1 subtypes must be improved.